Cargando…
Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids
PURPOSE: Celecoxib, an inhibitor of cyclooxygenase-2 (COX2), was investigated for enhancement of chemotherapeutic efficacy in cancer clinical trials. This study aimed to determine whether celecoxib combined with 5-fluorouracil or sorafenib or gefitinib is beneficial in HepG2 multicellular spheroids...
Autores principales: | Cui, Jie, Guo, Ya-Huan, Zhang, Hong-Yi, Jiang, Li-Li, Ma, Jie-Qun, Wang, Wen-Juan, Wang, Min-Cong, Yang, Cheng-Cheng, Nan, Ke-Jun, Song, Li-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938498/ https://www.ncbi.nlm.nih.gov/pubmed/24591842 http://dx.doi.org/10.2147/OTT.S56115 |
Ejemplares similares
-
Reversing platinum resistance in ovarian cancer multicellular spheroids by targeting Bcl-2
por: Yang, Ya’nan, et al.
Publicado: (2019) -
Generation of multicellular tumor spheroids with micro-well array for anticancer drug combination screening based on a valuable biomarker of hepatocellular carcinoma
por: Wang, Qi, et al.
Publicado: (2022) -
Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response
por: GALATEANU, BIANCA, et al.
Publicado: (2016) -
Unsuccessful mitosis in multicellular tumour spheroids
por: Molla, Annie, et al.
Publicado: (2017) -
Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics
por: MEENACH, SAMANTHA A., et al.
Publicado: (2016)